Reach and effectiveness of a HEARTS hypertension pilot project in Guatemala

Irmgardt Alicia Wellmann1, José Javier Rodríguez1, Benilda Batzin2

  • 1Institute of Nutrition of Central America and Panama Research Center for Prevention of Chronic Diseases Institute of Nutrition of Central America and Panama Guatemala City Guatemala Institute of Nutrition of Central America and Panama, Research Center for Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala.

Insights

The World Health Organization

Area of Science:

  • Cardiovascular disease research
  • Public health interventions
  • Hypertension management

Background:

  • The World Health Organization Global Hearts initiative (HEARTS) provides a technical package to improve population-level management of hypertension and cardiovascular disease risk factors.
  • Primary health care systems are crucial for managing chronic conditions like hypertension, especially in resource-limited settings.
  • Implementing standardized, evidence-based protocols is essential for effective hypertension control.

Purpose of the Study:

  • To describe the first pilot implementation of the HEARTS technical package within Guatemala's Ministry of Health (MOH) primary health care system.
  • To evaluate the feasibility and outcomes of adapting HEARTS strategies for sustainability in rural indigenous communities.
  • To assess the impact of the HEARTS intervention on patient reach and blood pressure control using the RE-AIM framework.

Main Methods:

  • A pilot project was conducted in six primary health care facilities across three rural indigenous municipalities in Guatemala, starting April 2022.
  • HEARTS-aligned strategies were adapted for local sustainability.
  • Outcomes were measured using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework, focusing on treatment count and blood pressure control metrics.

Main Results:

  • A statistically significant increase in monthly hypertension treatment counts was observed post-implementation (25 patients/month increase, P=.002, followed by 2.4 additional patients/month, P=.005).
  • Mean systolic blood pressure decreased significantly (-4.4 mmHg, P=0.028), while diastolic blood pressure showed a non-significant trend towards reduction (-0.9 mmHg, P=0.376).
  • The proportion of patients achieving blood pressure control (<130/80 mmHg) increased from 33.4% at baseline to 47.1% at 6 months (adjusted change 13.7%, P=0.027).

Conclusions:

  • The HEARTS model is feasible for implementation within the Guatemalan Ministry of Health's primary health care system.
  • The intervention demonstrated positive impacts on patient reach and blood pressure control, particularly in rural, indigenous populations.
  • Findings support the scalability of the HEARTS program for improving hypertension management nationwide, reaching the majority of patients seeking care.

Related Concept Videos

Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
605
Hypertension V: Nursing management01:23

Hypertension V: Nursing management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
1
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
2
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
2
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
522
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
483